Efficacy of protease inhibitor in combination with pegylated interferon and ribavirin to treat hepatitis C after living donor liver transplantation

被引：0
|
作者：
Miuma, Satoshi [1 ]
Ichikawa, Tatsuki [1 ]
Miyaaki, Hisamitsu [1 ]
Taura, Naota [1 ]
Nakao, Kazuhiko [1 ]
机构：
[1] Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki, Japan
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
704
引用
收藏
页码：542A / 542A
页数：1
相关论文
共 50 条
  • [1] Efficacy and Tolerability of Pegylated Interferon and Ribavirin in Combination with Simeprevir to Treat Hepatitis C Virus Infections After Living Donor Liver Transplantation
    Miuma, Satoshi
    Ichikawa, Tatsuki
    Miyaaki, Hisamitsu
    Haraguchi, Masafumi
    Tamada, Yoko
    Shibata, Hidetaka
    Taura, Naota
    Soyama, Akihiko
    Hidaka, Masaaki
    Takatsuki, Mitsuhisa
    Eguchi, Susumu
    Nakao, Kazuhiko
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (06): : 358 - 366
  • [2] Simeprevir/Pegylated Interferon/Ribavirin Triple Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation
    Shinoda, Masahiro
    Ebinuma, Hirotoshi
    Itano, Osamu
    Obara, Hideaki
    Kitago, Minoru
    Hibi, Taizo
    Abe, Yuta
    Yagi, Hiroshi
    Matsubara, Kentaro
    Amemiya, Ryusuke
    Mizota, Takamasa
    Yamagishi, Yoshiyuki
    Kanai, Takanori
    Kitagawa, Yuko
    TRANSPLANTATION, 2016, 100 : S137 - S137
  • [3] Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation
    Shinoda, Masahiro
    Ebinuma, Hirotoshi
    Itano, Osamu
    Yamagishi, Yoshiyuki
    Obara, Hideaki
    Kitago, Minoru
    Nakamoto, Nobuhiro
    Hibi, Taizo
    Yagi, Hiroshi
    Abe, Yuta
    Matsubara, Kentaro
    Chu, Po-sung
    Wakayama, Yuko
    Taniki, Nobuhito
    Yamaguchi, Akihiro
    Amemiya, Ryusuke
    Miyake, Rei
    Mizota, Takamasa
    Kanai, Takanori
    Kitagawa, Yuko
    HEPATOLOGY RESEARCH, 2016, 46 (11) : 1118 - 1128
  • [4] Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation
    Cicinnati, V. R.
    Iacob, S.
    Klein, C. G.
    Baba, H. A.
    Sotiropoulos, G. C.
    Hilgard, P.
    Erim, Y.
    Broelsch, C. E.
    Gerken, G.
    Beckebaum, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (02) : 291 - 303
  • [5] Impact of doble filtration plasmapheresis in combination with interferon and ribavirin for hepatitis C patients after living donor liver transplantation
    Taniguchi, M
    Furukawa, H
    Shimamura, T
    Suzuki, T
    Ohta, M
    Todo, S
    HEPATOLOGY, 2005, 42 (04) : 488A - 488A
  • [6] Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation
    Fernandez, Inmaculada
    Meneu, Juan Carlos
    Colina, Francisco
    Garcia, Ignacio
    Munoz, Raquel
    Castellano, Gregorio
    Fuertes, Antonio
    Abradelo, Manuel
    Lumbreras, Carlos
    Moreno, Enrique
    Antonio Solis-Herruzo, Jose
    LIVER TRANSPLANTATION, 2006, 12 (12) : 1805 - 1812
  • [7] Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation
    Kawaoka, Tomokazu
    Takahashi, Shoichi
    Tatsukawa, Yumiko
    Hiramatsu, Akira
    Hiraga, Nobuhiko
    Miki, Daiki
    Tsuge, Masataka
    Imamura, Michio
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Ochi, Hidenori
    Ishiyama, Kouhei
    Ide, Kentaro
    Tashiro, Hirotaka
    Ohdan, Hideki
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2014, 44 (12) : 1259 - 1264
  • [8] Cryptosporidiosis in a patient on PEG-interferon and ribavirin for recurrent hepatitis C after living donor liver transplantation
    Manz, M.
    Steuerwald, M.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (01) : 60 - 61
  • [9] An extended treatment protocol with pegylated interferon and ribavirin for hepatitis C recurrence after liver transplantation
    Nikroo Hashemi
    Victor Araya
    Kashif Tufail
    Laxmi Thummalakunta
    Eyob Feyssa
    Ashaur Azhar
    Mumtaz Niazi
    Jorge Ortiz
    World Journal of Hepatology, 2011, 3 (07) : 198 - 204
  • [10] Pegylated interferon ALFA-2A and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, DV
    Weaver, L
    Schafer, DF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S101 - S101
12345